Neil P. Shah

Also affiliated with Jacksonville College, University of California San Francisco Medical Center, Mayo Clinic in Florida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias”.

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

New England Journal of Medicine(2012)10.1056/nejmoa1205127

N/A

0.998DataRank · unranked

773 citations

Hagop Kantarjian, Neil P. Shah, Dale Bixby, Michael J. Mauro, Ian Flinn +11 more

Treatment‐free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5‐year analysis of DASFREE

British Journal of Haematology(2023)10.1111/bjh.18883

N/A

0.866DataRank · unranked

23 citations

Valentín García‐Gutiérrez, Antonio Jiménez‐Velasco, Sarah Larson, Susanne Saußele, Delphine Réa +8 more

Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680

Cancer Research(2006)10.1158/0008-5472.can-05-2788

N/A

0.845DataRank · unranked

278 citations

Neil P. Shah, Luke H. Chao, Markus Seeliger, Zdravko V. Milanov, William H. Biggs +7 more

Resistance to Allosteric Inhibitors

Journal of Molecular Biology(2025)10.1016/j.jmb.2025.169133

N/A

0.241DataRank · unranked

4 citations

Isabelle Kwan, Ariel Leyte-Vidal, Neil P. Shah, İvet Bahar, Markus A. Seeliger +1 more

Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitor

European Journal of Medicinal Chemistry(2021)10.1016/j.ejmech.2021.113776

N/A

0DataRank · unranked

23 citations

Naga Rajiv Lakkaniga, Jaideep B. Bharate, Nicholas McConnell, Xiuqi Wang, Anupreet Kharbanda +5 more

The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia

UNC Libraries(2024)10.17615/dgnw-zr34

N/A

0DataRank · unranked

0 citations

Craig T. Jordan, Stephen V. Frye, Catherine C. Smith, Dmitri Kireev, Katherine A. Minson +12 more

Absence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib

Leukemia(2024)10.1038/s41375-024-02353-0

N/A

0DataRank · unranked

11 citations

RosaAnna DeFilippis, Ian R Outhwaite, Isabelle Kwan, Ji Young Lee, Carlyn Leavitt +11 more

Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3458

N/A

0DataRank · unranked

16 citations

Aaron D. Viny, Evan Massi, Cyriac Kandoth, Nicholas D. Socci, Franck Rapaport +12 more

The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment

Haematologica(2021)10.3324/haematol.2020.261354

N/A

0DataRank · unranked

11 citations

Jonathan V. Nguyen, Adrian Stecula, Jon Akutagawa, Anthony V. Moorman, Benjamin S. Braun +9 more

Data from Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations

(2023)10.1158/0008-5472.c.6499347.v1

N/A

0DataRank · unranked

0 citations

Pratistha Ranjitkar, Corynn Kasap, Yibing Shan, David E. Shaw, Neil P. Shah +3 more